L-Train45 t1_j3iq7ws wrote on January 8, 2023 at 9:21 PM

Reply to comment by j4r8h in A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii

This study showed that taking it after being exposed doesn't decrease the chances of getting Covid at all. It was not known if it helped in that specific instance. I personally wouldnt recommend it at all.